Cordis报告说,其SELUTION SLR气球试验结果良好,表明外围动脉疾病患者的阻塞减少。 Cordis reports positive trial results for its SELUTION SLR balloon, showing reduced reblockage in peripheral artery disease patients.

Cordis报告说,其SELUTION SLR药物溶液气球的两次临床试验取得了积极成果,表明外围动脉疾病患者的治疗结果有所改善,包括目标损伤再血管化和复发率降低。 Cordis reported positive results from two clinical trials of its SELUTION SLR drug-eluting balloon, showing improved outcomes in patients with peripheral artery disease, including reduced rates of target lesion revascularization and restenosis. 调查结果在一次医疗会议上作了介绍,并证明该装置有可能加强长期血管性能。 The findings were presented at a medical conference and support the device’s potential to enhance long-term vascular patency.